Acute Respiratory Distress Syndrome (ARDS) Treatment Industry Size, Share & Growth Forecast 2033

Acute Respiratory Distress Syndrome (ARDS) Treatment by Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Types (Oral, Intravenous Injection, Intramuscular Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $391.2 million

CAGR: 3.1%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $391.2 million

CAGR: 3.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Acute Respiratory Distress Syndrome (ARDS) Treatment Market Overview

Acute Respiratory Distress Syndrome (ARDS) Treatment encompasses pharmacologic, ventilatory, and adjunctive interventions aimed at reversing life-threatening hypoxemia. The Acute Respiratory Distress Syndrome (ARDS) Treatment market size surpassed USD 2.9 billion in 2025, underpinned by a growth outlook of ~7.1% CAGR through 2033 as post-COVID-19 ICUs sustain demand for lung-protective ventilation, surfactant replacement, and anti-fibrotic therapies. This market forecast reflects intensified industry expansion in both developed and emerging economies, where synonyms such as ‘severe acute hypoxemic respiratory failure therapeutics’ and ‘ARDS pharmacotherapy’ collectively denote the expanding scope of evidence-based care.

Loading chart…

Key macro drivers include rising sepsis incidence, expanding geriatric ventilation needs, and reimbursement for ECMO; pivotal forces shaping the landscape are (i) high-frequency oscillatory and AI-guided ventilator technology shifts, (ii) stringent FDA and EMA guidance on lung-protective protocols, and (iii) hospital procurement centralization that intensifies competitive pricing. North America commands the largest revenue share owing to advanced critical-care infrastructure, while Asia-Pacific emerges as the fastest-growing region, propelled by ICU capacity build-outs in China and India and accelerated regulatory approvals for generic vasopressors and surfactants.

Report Overview

Report Attribute	Details
Market size value in 2025	391.20 million
Revenue forecast in 2033	682.27 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gilead Sciences Inc.; Terumo Corporation; Getinge Ab; Livanova Plc; Medtronic; Alung Technologies, Inc.; Armstrong Medical; Besmed Health Business Corp.; Dragerwerk Ag & Co. Kgaa; Eurosets; F. Hoffmann-la Roche Ltd.; Fisher & Paykel Healthcare Limited; Fresenius Se & Co. Kgaa; Hamilton Medical; Nice Neotech Medical Systems Pvt.ltd.; Nipro; Pfizer Inc.; Resmed; Smiths Medical; Weinmann Emergency Medical Technology Gmbh+co. Kg
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

11 items

1. Executive Summary

2. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital Pharmacy

6.1.2. Retail Pharmacy

6.1.3. Online Pharmacy

6.2. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Oral

6.2.2. Intravenous Injection

6.2.3. Intramuscular Injection

6.3. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Competition by Key Manufacturers

8.1. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Acute Respiratory Distress Syndrome (ARDS) Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Gilead Sciences Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Terumo Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Getinge Ab

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Livanova Plc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Medtronic

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Alung Technologies, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Armstrong Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Besmed Health Business Corp.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Dragerwerk Ag & Co. Kgaa

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Eurosets

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. F. Hoffmann-la Roche Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Fisher & Paykel Healthcare Limited

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Fresenius Se & Co. Kgaa

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Hamilton Medical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Nice Neotech Medical Systems Pvt.ltd.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Nipro

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Pfizer Inc.

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Resmed

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Smiths Medical

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Weinmann Emergency Medical Technology Gmbh+co. Kg

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market

Figure 4: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market: Drivers

Figure 5: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market: Challenges

Figure 6: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market: Trends

Figure 7: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market: Opportunity

Figure 8: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market: Restraint

Figure 9: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Value (USD Million) By Region

Figure 15: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Value (USD Million) By Region

Figure 23: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Value (USD Million) By Region

Table 10: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Gilead Sciences Inc. Basic Information And Sales Area

Table 31: Gilead Sciences Inc.. Products Portfolio

Table 32: Terumo Corporation Basic Information And Sales Area

Table 33: Terumo Corporation. Products Portfolio

Table 34: Getinge Ab Basic Information And Sales Area

Table 35: Getinge Ab. Products Portfolio

Table 36: Livanova Plc Basic Information And Sales Area

Table 37: Livanova Plc. Products Portfolio

Table 38: Medtronic Basic Information And Sales Area

Table 39: Medtronic. Products Portfolio

Table 40: Alung Technologies, Inc. Basic Information And Sales Area

Table 41: Alung Technologies, Inc.. Products Portfolio

Table 42: Armstrong Medical Basic Information And Sales Area

Table 43: Armstrong Medical. Products Portfolio

Table 44: Besmed Health Business Corp. Basic Information And Sales Area

Table 45: Besmed Health Business Corp.. Products Portfolio

Table 46: Dragerwerk Ag & Co. Kgaa Basic Information And Sales Area

Table 47: Dragerwerk Ag & Co. Kgaa. Products Portfolio

Table 48: Eurosets Basic Information And Sales Area

Table 49: Eurosets. Products Portfolio

Table 50: F. Hoffmann-la Roche Ltd. Basic Information And Sales Area

Table 51: F. Hoffmann-la Roche Ltd.. Products Portfolio

Table 52: Fisher & Paykel Healthcare Limited Basic Information And Sales Area

Table 53: Fisher & Paykel Healthcare Limited. Products Portfolio

Table 54: Fresenius Se & Co. Kgaa Basic Information And Sales Area

Table 55: Fresenius Se & Co. Kgaa. Products Portfolio

Table 56: Hamilton Medical Basic Information And Sales Area

Table 57: Hamilton Medical. Products Portfolio

Table 58: Nice Neotech Medical Systems Pvt.ltd. Basic Information And Sales Area

Table 59: Nice Neotech Medical Systems Pvt.ltd.. Products Portfolio

Table 60: Nipro Basic Information And Sales Area

Table 61: Nipro. Products Portfolio

Table 62: Pfizer Inc. Basic Information And Sales Area

Table 63: Pfizer Inc.. Products Portfolio

Table 64: Resmed Basic Information And Sales Area

Table 65: Resmed. Products Portfolio

Table 66: Smiths Medical Basic Information And Sales Area

Table 67: Smiths Medical. Products Portfolio

Table 68: Weinmann Emergency Medical Technology Gmbh+co. Kg Basic Information And Sales Area

Table 69: Weinmann Emergency Medical Technology Gmbh+co. Kg. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Value (USD Million) By Region

Table 75: Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

FAQs

1. What is the projected Compound Annual Growth Rate (CAGR) of the Acute Respiratory Distress Syndrome (ARDS) Treatment?

The projected CAGR is approximately 3.1%.

2. Which companies are prominent players in the Acute Respiratory Distress Syndrome (ARDS) Treatment?

Key companies in the market include Gilead Sciences Inc., Terumo Corporation, Getinge Ab, Livanova Plc, Medtronic, Alung Technologies, Inc., Armstrong Medical, Besmed Health Business Corp., Dragerwerk Ag & Co. Kgaa, Eurosets, F. Hoffmann-la Roche Ltd., Fisher & Paykel Healthcare Limited, Fresenius Se & Co. Kgaa, Hamilton Medical, Nice Neotech Medical Systems Pvt.ltd., Nipro, Pfizer Inc., Resmed, Smiths Medical, Weinmann Emergency Medical Technology Gmbh+co. Kg.

3. What are the main segments of the Acute Respiratory Distress Syndrome (ARDS) Treatment?

The market segments include Type, Application.

4. Can you provide details about the market size?

The market size is estimated to be 391.2

5. What are some drivers contributing to market growth?

Increasing Demand for Various Applications to Aid Market Growth.

6. What are the notable trends driving market growth?

Increasing Demand for Various Applications to Aid Market Growth.

7. Are there any restraints impacting market growth?

Increasing Demand for Various Applications to Aid Market Growth.

8. Can you provide examples of recent developments in the market?

Recent developments data is not available.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3350.00, USD 5025.00, and USD 6700.00 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in 391.2.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Acute Respiratory Distress Syndrome (ARDS) Treatment," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Acute Respiratory Distress Syndrome (ARDS) Treatment report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided with the report for further details.

14. How can I stay updated on further developments or reports in the Acute Respiratory Distress Syndrome (ARDS) Treatment?

To stay informed about further developments, trends, and reports in the Acute Respiratory Distress Syndrome (ARDS) Treatment, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Contact for Full Report

Loading report content...

Acute Respiratory Distress Syndrome (ARDS) Treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	391.20 million
Revenue forecast in 2033	682.27 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Gilead Sciences Inc.; Terumo Corporation; Getinge Ab; Livanova Plc; Medtronic; Alung Technologies, Inc.; Armstrong Medical; Besmed Health Business Corp.; Dragerwerk Ag & Co. Kgaa; Eurosets; F. Hoffmann-la Roche Ltd.; Fisher & Paykel Healthcare Limited; Fresenius Se & Co. Kgaa; Hamilton Medical; Nice Neotech Medical Systems Pvt.ltd.; Nipro; Pfizer Inc.; Resmed; Smiths Medical; Weinmann Emergency Medical Technology Gmbh+co. Kg
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Table of Contents